EUVIMEDOpdag EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY-NC 4.0

Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis

Mushfiqur R Siddique, Muzzafar Haque, Francisco Idalsoaga iD, Luis Antonio Diaz iD, Gene Im iD, Ashwani K Singal iD, Stephen Hoang iD, Mohammad Qasim Khan iD, Juan Pablo Arab iD

Alimentary Pharmacology & Therapeutics · 2025-11 · 62 (9) · 866-876

DOI: 10.1111/apt.70383 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, published online on 2025-09-20. Written by Mushfiqur R Siddique and 8 co-authors. Institution: Department of Internal Medicine, Jamaica Hospital Medical Center, New York, USA. Major MEDLINE topics: Hepatitis, Alcoholic. Cited 14 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Severe alcohol‐associated hepatitis (sAH) is a life‐threatening condition. Despite advances in clinical management, prognosis remains poor and long‐term effectiveness of available therapies is uncertain. We conducted a systematic review and meta‐analysis to evaluate short‐term mortality (28, 60, and 90‐day) trends in sAH over the past five decades.

Methods

We searched PubMed, EMBASE, and Scopus from database inception to February 2024 for studies reporting 28, 60, and 90‐day mortality in patients with sAH. Pooled mortality estimates were calculated using a random‐effects meta‐regression model. We assessed heterogeneity using the I 2 statistic and explored sources of heterogeneity through subgroup and meta‐regression analyses. Separate Bayesian mixed‐effects binomial models were used to estimate the posterior distribution of mortality probability, updated sequentially across calendar time.

Results

34 studies comprising 1586 patients with sAH were included. Pooled mortality rates were 26.8% (95% CI: 21.0%–33.5%) at 28 days, 35.1% (95% CI: 28.3%–42.5%) at 60 days, and 43.7% (95% CI: 34.6%–53.3%) at 90 days. Mortality increased steadily with follow‐up time. Substantial heterogeneity was observed, as expected in pooled proportion meta‐analysis (I 2 > 80%). Although cumulative Bayesian analysis showed that average 28‐day mortality declined from over 50% in the 1970s to ~25% after 2000, a formal decade‐based analysis indicated no statistically credible improvement in short‐term mortality was detected overall in the past four decades. In multivariable models adjusting for follow‐up time, the Model for End‐Stage Liver Disease (MELD) score was significantly associated with mortality.

Conclusions

Short‐term mortality in sAH remains high and has not improved in recent decades. These findings highlight the urgent need for effective therapies, improved patient selection for early liver transplantation, and better prognostic tools to guide clinical decision‐making.

Subjects

MeSH terms (MEDLINE)

Hepatitis, AlcoholicHumansRisk FactorsBayes TheoremSeverity of Illness Index

Author keywords

alcoholalcoholic cirrhosisalcoholic hepatitisalcoholic liver diseasealcohol‐associated liver diseasemeta analysismortalitysystematic review

Authors and institutions

  • Department of Internal Medicine, Jamaica Hospital Medical Center, New York, USA.
  • Department of Internal Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
  • Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.
  • Department of Gastroenterology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, California, USA.
  • Center for Liver Disease and Transplantation, Columbia University, Vagelos College of Physicians and Surgeons, New York, USA.

ORCID profiles: Francisco Idalsoaga, Luis Antonio Diaz, Gene Im, Ashwani K Singal, Stephen Hoang, Mohammad Qasim Khan, Juan Pablo Arab

Cite

APA

Siddique, M. R., Haque, M., Idalsoaga, F., Diaz, L. A., Im, G., Singal, A. K., Hoang, S., Khan, M. Q., & Arab, J. P. (2025). Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis. Alimentary Pharmacology & Therapeutics, 62(9), 866-876. https://doi.org/10.1111/apt.70383

Vancouver

Siddique MR, Haque M, Idalsoaga F, Diaz LA, Im G, Singal AK, et al. Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis. Alimentary Pharmacology & Therapeutics. 2025;62(9):866-876. doi:10.1111/apt.70383

BibTeX
@article{Siddique2025,
  author = {Siddique, Mushfiqur R and Haque, Muzzafar and Idalsoaga, Francisco and Diaz, Luis Antonio and Im, Gene and Singal, Ashwani K and Hoang, Stephen and Khan, Mohammad Qasim and Arab, Juan Pablo},
  title = {Meta‐Analysis: Mortality Trends and Risk Factors in Severe Alcohol‐Associated Hepatitis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {62},
  number = {9},
  pages = {866--876},
  doi = {10.1111/apt.70383}
}
Start for free →